Search by Drug Name or NDC
NDC 65219-0445-22 Etomidate 2 mg/mL Details
Etomidate 2 mg/mL
Etomidate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ETOMIDATE.
Product Information
NDC | 65219-0445 |
---|---|
Product ID | 65219-445_446487f1-002e-41d3-846a-67570e797171 |
Associated GPIs | 70400010002020 |
GCN Sequence Number | 030871 |
GCN Sequence Number Description | etomidate VIAL 2 MG/ML INTRAVEN |
HIC3 | H2C |
HIC3 Description | GENERAL ANESTHETICS,INJECTABLE |
GCN | 12831 |
HICL Sequence Number | 001554 |
HICL Sequence Number Description | ETOMIDATE |
Brand/Generic | Generic |
Proprietary Name | Etomidate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Etomidate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/mL |
Substance Name | ETOMIDATE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | General Anesthesia [PE], General Anesthetic [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA215028 |
Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0445-22 (65219044522)
NDC Package Code | 65219-445-22 |
---|---|
Billing NDC | 65219044522 |
Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-445-22) / 10 mL in 1 VIAL, SINGLE-DOSE (65219-445-12) |
Marketing Start Date | 2023-10-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |